Philip Puchas
Overview
Explore the profile of Philip Puchas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
140
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olkus A, Tomczak A, Berger A, Rauber C, Puchas P, Wehling C, et al.
Target Oncol
. 2024 Feb;
19(2):213-221.
PMID: 38416377
Background: The combination of gemcitabine and cisplatin (gem/cis) with the anti-PD-L1-antibody durvalumab was recently approved as first line therapy for biliary tract cancer (BTC) based on the results of the...
2.
Golob-Schwarzl N, Puchas P, Gogg-Kamerer M, Weichert W, Goppert B, Haybaeck J
Anticancer Res
. 2020 Jun;
40(6):3109-3118.
PMID: 32487605
Background/aim: Pancreatic cancer is one of the deadliest forms of cancer and ranks among the leading causes of cancer-related death worldwide. The most common histological type is ductal adenocarcinoma (PDAC),...
3.
Lembeck A, Puchas P, Hutterer G, Barth D, Terbuch A, Bauernhofer T, et al.
Noncoding RNA
. 2020 Jan;
6(1).
PMID: 31906360
Testicular germ cell tumors (TGCTs) are the most commonly diagnosed malignancies in younger men. The monitoring of disease course and recurrence is supported by traditional tumor markers, including α-fetoprotein (AFP)....
4.
Dahlem C, Barghash A, Puchas P, Haybaeck J, Kessler S
Int J Mol Sci
. 2019 Jul;
20(13).
PMID: 31261900
The insulin-like growth factor 2 () mRNA binding protein IMP2 (IGF2BP2) is an oncogenic protein known to be overexpressed in different tumor types. Pancreatic cancer is a very lethal cancer...
5.
Liao L, Schneider K, Galvez E, Frissen M, Marschall H, Su H, et al.
Gut
. 2019 Mar;
68(8):1477-1492.
PMID: 30872395
Objective: There is a striking association between human cholestatic liver disease (CLD) and inflammatory bowel disease. However, the functional implications for intestinal microbiota and inflammasome-mediated innate immune response in CLD...